addressalign-toparrow-leftarrow-rightbackbellblockcalendarcameraccwchatcheckchevron-downchevron-leftchevron-rightchevron-small-downchevron-small-leftchevron-small-rightchevron-small-upchevron-upcircle-with-crosscrosseditemptyheartfacebookfolderfullheartglobegmailgoogleimagesinstagramlinklocation-pinmagnifying-glassmailminusmoremuplabelShape 3 + Rectangle 1outlookpersonplusprice-ribbonImported LayersImported LayersImported Layersshieldstartrashtriangle-downtriangle-uptwitteruseryahoo

Launching the Burrill Israel Fund

  • May 24, 2012 · 5:00 PM
  • This location is shown only to members

Launching of the Burill Israel Fund

May 24, 2012 at 17:00 sharp

Jerusalem is one of the principal poles on R&D in Life Sciences in Israel, with roughly half of its medical research and a significant biotechnology industry. For this reason, Jerusalem Mayor, Mr. Nir Barkat, together with the City Council has marked as top priority the development of Jerusalem as the capital of the Israeli Bio-med Industry.

Moderator: Michael Horesh, JBNF

Greetings from
Mayor Nir Barkat

Deputy Mayor Naomi Tsur

Opening: Mr Avi Salman, Director, Business Development, Business Promotion Department

Ms. Chen Levin, Executive Director, BioJerusalem

Guest of Honor:

Launching Burrill Israel Fund - The Latest Jerusalem BioMed Fund

Jeffrey Miller,

Special Advisor to Burrill & Company and CEO of Miller Communications Group

Launching of the JBNF-BioMed Forum, the new JBNF section dedicated to business networking in Bio-Med in the Jerusalem area.

Welcome the JBNF-BioMed Forum new organizing committee:

Esther Moscatel-Mendelsohn, Kerentech,

Daniel Green, Yigal Arnon & Co., Law Firm

Joshua Hextor, BioLine Rx

Avigail Frij

About Jeffrey Miller:

Jeffrey Miller founded Miller Communications Group (MCG) in 2008, after building a successful career in the Life Science and Information Technology industries. MCG is a specialty consulting firm offering capital and investor relation services, business development, marketing and media services to early stage Life Science and Technology companies. From 2003 to 2008, Mr. Miller was Managing Director of Burrill & Company’s Life Sciences Media Group and on the Executive Committee.

He launched and managed a number of media publications including The Journal of Life Sciences and The Biotech State of the Industry Report. He also launched and led such re-known and respected annual conferences as The Personalized Medicine Meeting, The CEO Biotech Meeting at Laguna Niguel, The India/China Life Sciences Meeting, and The Stem Cell Summit. These annual events enabled Burrill & Company to stay on the cutting edge of the life sciences industry, to maintain ties with the leading companies, CEOs and the most promising new technologies – making Burrill & Company the “best networked” company in the industry.

Prior to Burrill & Company, Miller spent nearly 20 years in Information Technology media, launching and managing publications, expositions and conferences. Most notable amongst these are The Internet Industry Standard and, one of the fastest growing publications in the US in the ‘90s, Windows Magazine, PC Magazine, MacUser Magazine, Visual Basic Programmer’s Journal, Java Pro Magazine, Telecom Asia, Wireless Asia and America’s Network. Miller worked as a media executive with Nielsen Business Media, IDG Publications, CMP Publications, and Ziff-Davis Publishing. Early in his career he was an Account Executive with Ted Bates & Company and Savitt, Tobias & Balk Advertising Agencies in NY. Jeff has an MBA in Marketing Management.

More about the G. Steven Burrill and the Burill & Company:

G. Steven Burrill has been involved in the growth and prosperity of the biotechnology industry for over 40 years. Mr. Burrill founded and has been Chief Executive Officer of Burrill & Company, a venture capital and merchant banking firm, since 1994. Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and coordinating the firm's services to clients in the field of biotechnology, life sciences, high technology, and manufacturing worldwide. He currently serves on the Boards of Directors of AliveCor (Chairman), Catalyst Biosciences, Depomed (NASDAQ: DEPO), NewBridge, Novadaq (TSX: NDQ), Targacept (NASDAQ: TRGT) and XDx. Previously he served as Chairman of the Boards of BioImagene, Abunda Nutrition and Pharmasset.

The Burrill & Company is a diversified global financial services firm focused on the life sciences industry. With $1.5 billion in assets under management, the firm's businesses include venture capital/private equity, merchant banking, and media. By leveraging the scientific and business networks of its team, Burrill & Company has established unrivaled access and visibility in the life sciences industry. Headquartered in San Francisco, the company oversees a global network of offices throughout the United States, Latin America, Europe, and Asia.

Join or login to comment.

  • paul k.

    as an experienced business 2 business sales leader, I am looking to bring my considerable expertise to this market to benefit a company driving export growth.

    October 24, 2012

  • Joe S.

    Excellent meeting! The prospect of the Burrill fund is very exciting for Israel, and especially for Jerusalem.

    I very much enjoyed the Mayor's comments and Jeff Miller's presentation.

    Onwards and upwards!

    May 25, 2012

  • Barry & Dorraine W.

    Very informative

    May 25, 2012

  • Joe van Z.

    We will need your ideas, suggestions and initiatives to succeed. JBNF would like to congratulate the JBNF-BioMed team (Ester Moscatel-Mendelsohn, Daniel Green, Joshua Hexter and Avigail Frij).
    Starting in June, BioMed events will be organized by JBNF-BioMed ONLY on a monthly basis (taking a break in August). JBNF will go back to its regular non BioMed business networking activities.

    May 23, 2012

  • Joe van Z.

    The opening of the Burrill Israel fund in Jerusalem is expected to be the largest Biomed VC fund to be based in Jerusalem. The vision
    of the mayor, Nir Barkat, will be taking another step forward in making Jerusalem the BioMed capital in Israel. The JBNF-BioMed forum is an initiative of JBNF and the City of Jerusalem to create a critical mass in the Jerusalem's BioMed community with regular business networking events that will give Jerusalem a competitive edge.

    May 23, 2012

  • Joe van Z.

    Pl arrive early at 16:45 and be seated at 17:00 when our mayor, Nir Barkat starts the event. Pl note that traffic is heavy (Recommended is using the electric tram stops outside Safra Square).

    May 23, 2012

  • Shai Melcer, LLM, P.

    The HUB center (HUJI-Bioseed) will be presented and promoted at this BioJerusalem brunch reception in the 2012 ILSI Bio-Med. We can make your Biotech start-up go higher, faster and cheaper! Come visit us!!

    May 22, 2012

  • Joe van Z.

    BioJerusalem brunch reception at ILSI Biomed May. 22, 2012 Join us for a brunch reception on May 22nd at 11:00am at the ILSI Biomed Conference in TA in the BioJerusalem booth (booth #3) Get updates on some exciting new developments in Jerusalem's life science community: Moty Hazan, CEO, JDA Chen Levin, Executive Director, BioJM Jeffery Miller, Founder and CEO, Miller Comm Gr Michael Horesh, MultiChann

    May 19, 2012

  • Joe van Z.

    Avigail Frij has just opened a new Linked group for JBNF

    this is in addition to our facebook group at:

    We would appreciate it if you would join and "like" these two groups.

    May 16, 2012

  • Shai Melcer, LLM, P.

    Boosting Biomed in Jerusalem is long overdue. Starting this forum is a great idea!
    I will be presenting the HUJI-Bioseed concept next week and hope for many follow-ups and cooperations via JBNF Biomed.
    See you all soon!

    May 15, 2012

  • Joe van Z.

    For those who are only involved in Bio-Med, we have start up JBNF BioMed which can be seen at

    May 15, 2012

Our Sponsors

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy